Literature DB >> 3743101

Prolonged isoflurane anesthesia in status asthmaticus.

M I Bierman, M Brown, O Muren, R L Keenan, F L Glauser.   

Abstract

We report a case of status asthmaticus that was unresponsive to the usual agents. The use of an inhalational anesthetic agent allowed us to ventilate the patient with lower inspiratory pressures; however, lasting improvement did not occur until she mobilized large quantities of secretions. To our knowledge, this is the first clinical report on the use of isoflurane anesthesia to treat severe asthma. Despite prolonged administration, there were no significant side-effects. This case demonstrates both the benefits and limitations of such therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3743101     DOI: 10.1097/00003246-198609000-00017

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

Review 1.  Pharmacologic management of the hospitalized pediatric asthma patient.

Authors:  K A Hardin; H J Kallas; R J McDonald
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 2.  When conventional asthma therapies fail.

Authors:  J Jones; S Murin
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

3.  [Functioning of the anaesthetic conserving device: aspects to consider for use in inhalational sedation].

Authors:  A Meiser; M Bellgardt; H Vogelsang; C Sirtl; T Weber
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

4.  [AnaConDa].

Authors:  C Sirtl; H Laubenthal; A Meiser
Journal:  Anaesthesist       Date:  2007-12       Impact factor: 1.041

5.  [Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system].

Authors:  J Kompardt; K Schärff; K Kubosch; C Pohl; M Bomplitz; J Soukup
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

6.  Targeted Versus Continuous Delivery of Volatile Anesthetics During Cholinergic Bronchoconstriction.

Authors:  Jarred R Mondoñedo; John S McNeil; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  J Eng Sci Med Diagn Ther       Date:  2018-05-09

Review 7.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 8.  Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review.

Authors:  Jennifer Herzog-Niescery; Hans-Martin Seipp; Thomas Peter Weber; Martin Bellgardt
Journal:  J Clin Monit Comput       Date:  2017-08-31       Impact factor: 2.502

9.  Volatile Anesthetics and the Treatment of Severe Bronchospasm: A Concept of Targeted Delivery.

Authors:  Jarred R Mondoñedo; John S McNeil; Samir D Amin; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

10.  Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety.

Authors:  E M Spencer; S M Willatts
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.